vs
Barnes & Noble Education, Inc.（BNED）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Barnes & Noble Education, Inc.的1.0倍（$622.0M vs $598.2M），Royalty Pharma plc净利率更高（34.4% vs 4.2%，领先30.3%），Barnes & Noble Education, Inc.同比增速更快（6.9% vs 4.8%），过去两年Barnes & Noble Education, Inc.的营收复合增速更高（20.0% vs 4.6%）
巴诺教育旗下的巴诺书店是美国门店数量最多的图书零售商，目前在美国各地经营着七百多家线下实体门店，是美国本土颇具影响力的线下图书零售企业，深耕图书零售领域多年。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
BNED vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.0倍
$598.2M
营收增速更快
BNED
高出2.1%
4.8%
净利率更高
RPRX
高出30.3%
4.2%
两年增速更快
BNED
近两年复合增速
4.6%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $598.2M | $622.0M |
| 净利润 | $25.0M | $214.2M |
| 毛利率 | 21.7% | — |
| 营业利润率 | 6.8% | 62.4% |
| 净利率 | 4.2% | 34.4% |
| 营收同比 | 6.9% | 4.8% |
| 净利润同比 | -49.7% | 2.9% |
| 每股收益（稀释后） | $0.72 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNEDRPRX
| Q4 25 | $598.2M | $622.0M | ||
| Q3 25 | $274.2M | $609.3M | ||
| Q2 25 | $233.0M | $578.7M | ||
| Q1 25 | $419.7M | $568.2M | ||
| Q4 24 | $559.7M | $593.6M | ||
| Q3 24 | $250.9M | $564.7M | ||
| Q2 24 | $192.7M | $537.3M | ||
| Q1 24 | $415.4M | $568.0M |
净利润BNEDRPRX
| Q4 25 | $25.0M | $214.2M | ||
| Q3 25 | $-18.3M | $288.2M | ||
| Q2 25 | $-23.0M | $30.2M | ||
| Q1 25 | $17.9M | $238.3M | ||
| Q4 24 | $43.2M | $208.2M | ||
| Q3 24 | $-103.9M | $544.0M | ||
| Q2 24 | $-41.9M | $102.0M | ||
| Q1 24 | $-9.3M | $4.8M |
毛利率BNEDRPRX
| Q4 25 | 21.7% | — | ||
| Q3 25 | 20.2% | — | ||
| Q2 25 | 30.3% | — | ||
| Q1 25 | 22.3% | — | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 28.7% | — | ||
| Q1 24 | 24.2% | — |
营业利润率BNEDRPRX
| Q4 25 | 6.8% | 62.4% | ||
| Q3 25 | -8.4% | 70.1% | ||
| Q2 25 | -4.9% | 36.3% | ||
| Q1 25 | 4.5% | 94.0% | ||
| Q4 24 | 8.4% | 60.9% | ||
| Q3 24 | -15.4% | — | ||
| Q2 24 | -16.3% | 50.2% | ||
| Q1 24 | 0.4% | -13.0% |
净利率BNEDRPRX
| Q4 25 | 4.2% | 34.4% | ||
| Q3 25 | -6.7% | 47.3% | ||
| Q2 25 | -9.9% | 5.2% | ||
| Q1 25 | 4.3% | 41.9% | ||
| Q4 24 | 7.7% | 35.1% | ||
| Q3 24 | -41.4% | 96.3% | ||
| Q2 24 | -21.7% | 19.0% | ||
| Q1 24 | -2.2% | 0.8% |
每股收益（稀释后）BNEDRPRX
| Q4 25 | $0.72 | $0.49 | ||
| Q3 25 | $-0.54 | $0.67 | ||
| Q2 25 | $2.97 | $0.07 | ||
| Q1 25 | $0.59 | $0.55 | ||
| Q4 24 | $1.63 | $0.46 | ||
| Q3 24 | $-7.69 | $1.21 | ||
| Q2 24 | $-15.68 | $0.23 | ||
| Q1 24 | $-3.49 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.7M | $618.7M |
| 总债务越低越好 | $122.5M | $9.0B |
| 股东权益账面价值 | $283.2M | $9.7B |
| 总资产 | $1.1B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资BNEDRPRX
| Q4 25 | $11.7M | $618.7M | ||
| Q3 25 | $7.3M | $938.9M | ||
| Q2 25 | $9.1M | $631.9M | ||
| Q1 25 | $9.2M | $1.1B | ||
| Q4 24 | $11.6M | $929.0M | ||
| Q3 24 | $8.2M | $950.1M | ||
| Q2 24 | $10.5M | $1.8B | ||
| Q1 24 | $8.1M | $843.0M |
总债务BNEDRPRX
| Q4 25 | $122.5M | $9.0B | ||
| Q3 25 | $170.0M | $8.9B | ||
| Q2 25 | $103.1M | $8.0B | ||
| Q1 25 | $141.2M | $7.6B | ||
| Q4 24 | $177.6M | $7.6B | ||
| Q3 24 | $221.9M | $7.6B | ||
| Q2 24 | $196.3M | $7.6B | ||
| Q1 24 | $30.2M | $6.1B |
股东权益BNEDRPRX
| Q4 25 | $283.2M | $9.7B | ||
| Q3 25 | $256.5M | $9.6B | ||
| Q2 25 | $272.2M | $9.5B | ||
| Q1 25 | $292.9M | $9.8B | ||
| Q4 24 | $211.4M | $10.3B | ||
| Q3 24 | $149.8M | $10.3B | ||
| Q2 24 | $80.4M | $9.8B | ||
| Q1 24 | $121.5M | $9.9B |
总资产BNEDRPRX
| Q4 25 | $1.1B | $19.6B | ||
| Q3 25 | $950.8M | $19.3B | ||
| Q2 25 | $790.3M | $18.3B | ||
| Q1 25 | $1.1B | $17.6B | ||
| Q4 24 | $1.0B | $18.2B | ||
| Q3 24 | $973.2M | $18.0B | ||
| Q2 24 | $909.9M | $17.7B | ||
| Q1 24 | $1.2B | $16.1B |
负债/权益比BNEDRPRX
| Q4 25 | 0.43× | 0.92× | ||
| Q3 25 | 0.66× | 0.93× | ||
| Q2 25 | 0.38× | 0.84× | ||
| Q1 25 | 0.48× | 0.78× | ||
| Q4 24 | 0.84× | 0.74× | ||
| Q3 24 | 1.48× | 0.74× | ||
| Q2 24 | 2.44× | 0.78× | ||
| Q1 24 | 0.25× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $66.2M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $61.9M | — |
| 自由现金流率自由现金流/营收 | 10.4% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | 2.65× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $-4.6M | — |
8季度趋势，按日历期对齐
经营现金流BNEDRPRX
| Q4 25 | $66.2M | $827.1M | ||
| Q3 25 | $-67.6M | $702.6M | ||
| Q2 25 | $52.6M | $364.0M | ||
| Q1 25 | $-41.9M | $596.1M | ||
| Q4 24 | $47.4M | $742.5M | ||
| Q3 24 | $-143.5M | $703.6M | ||
| Q2 24 | $81.7M | $658.2M | ||
| Q1 24 | $-35.8M | $664.6M |
自由现金流BNEDRPRX
| Q4 25 | $61.9M | — | ||
| Q3 25 | $-71.3M | — | ||
| Q2 25 | $49.5M | — | ||
| Q1 25 | $-44.7M | — | ||
| Q4 24 | $44.4M | — | ||
| Q3 24 | $-147.5M | — | ||
| Q2 24 | $79.1M | — | ||
| Q1 24 | $-39.0M | — |
自由现金流率BNEDRPRX
| Q4 25 | 10.4% | — | ||
| Q3 25 | -26.0% | — | ||
| Q2 25 | 21.3% | — | ||
| Q1 25 | -10.7% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | -58.8% | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | -9.4% | — |
资本支出强度BNEDRPRX
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 0.8% | — |
现金转化率BNEDRPRX
| Q4 25 | 2.65× | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | -2.34× | 2.50× | ||
| Q4 24 | 1.10× | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNED
| Course Materials Product | $459.3M | 77% |
| General Merchandise Product | $112.9M | 19% |
| Serviceand Other | $26.1M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
